Skip to content
PeptideAgent

Compounding pharmacies in Tennessee

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Tennessee Board of Pharmacy (Tennessee Department of Health) regulates compounding pharmacies in Tennessee. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Tennessee at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Tennessee

No verified compounding pharmacies serving Tennessee are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Tennessee

The Tennessee Board of Pharmacy licenses pharmacies under title 63, chapter 10 of the Tennessee Code. Section 63-10-216 is a compounding-specific statute: an out-of-state pharmacy must be inspected by its home-state regulator and provide the most recent inspection (within the previous 12 months) before initial Tennessee licensure as a compounding pharmacy, licensed compounding pharmacies must report disciplinary action by other regulators to the Board within 14 business days, compounding must follow the USP chapters the Board adopts by rule, and sterile compounders must report the quantity of sterile compounded products dispensed. Board rule chapter 1140-07 sets the sterile compounding standards. Tennessee has no separate state list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [2] [3] [4]

Compounded GLP-1 access in Tennessee

Tennessee has not adopted a looser rule, and because injectable GLP-1s are sterile preparations, a pharmacy compounding them for a Tennessee patient must also meet rule chapter 1140-07 and, if out of state, the section 63-10-216 inspection requirement. [2] [3] [6]

Research use only sellers in Tennessee

Under title 63, chapter 10, only licensed pharmacies may dispense prescription drugs to Tennessee patients, so a seller shipping "research use only" injectable peptides to Tennessee consumers is not operating under Board of Pharmacy licensure. [1] [7]

How to check a compounding pharmacy in Tennessee

  1. Search the Tennessee Board of Pharmacy (Tennessee Department of Health) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Tennessee requires before it ships to you. [1] [2] [3] [4]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Tennessee. [1] [7]

Common questions in Tennessee

What does an out-of-state compounding pharmacy need to ship peptides to Tennessee?

A Tennessee pharmacy license issued after the pharmacy submits an inspection by its home-state regulator from the previous 12 months, as section 63-10-216 requires. It must also report outside disciplinary actions to the Tennessee Board within 14 business days and follow Board-adopted USP compounding standards. [1] [2]

Can a Tennessee pharmacy compound peptides that are not on the FDA bulks list?

Generally no. Tennessee has no state bulks list, so the federal 503A test applies: the substance must be a component of an approved drug, have a USP or NF monograph, or be on the FDA 503A bulks list. Peptides placed in FDA Category 2 cannot be compounded. [2] [4] [5]

All peptide legal questions for Tennessee

Sources

  1. [1]Tennessee Board of Pharmacy (Tennessee Department of Health)
  2. [2]Tennessee Code section 63-10-216, Compounding pharmacies
  3. [3]Rules of the Tennessee Board of Pharmacy chapter 1140-07, sterile compounding standards
  4. [4]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  5. [5]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  6. [6]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  7. [7]21 U.S.C. 331, Prohibited acts